Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 08/2/16 → 08/31/18 |
Funding
- National Inst of Neurological Disorders & Stroke: $39,483.20
An Exploratory Phase II Study to Determine the Tolerability, Safety, and Activity of a Novel Vasopressin 1a Receptor Antagonist (SRX246) in Irritable Subjects with Huntington's Disease (HD)
- Schwartz, Guy (PI)
- Coyle, Patricia K (CoPI)
Project: Research